← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2004Last known activity
May 29, 2023
Timeline
1990s
- Jan 1, 1994
Grupo Espanol de Investigacion en Sarcomas— Founded
Drugs by trial phase (20 distinct, 19 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Chondrosarcoma
- Desmoid Tumors
- Desmoplastic Small Round Cell Tumor
- Drug-Related Side Effects and Adverse Reactions
- Gastrointestinal Stromal Tumors
- Leiomyosarcoma
- Liposarcoma
- Liposarcoma, Myxoid
- Neoplasms
- Neoplasms, Fibrous Tissue
- Neuroectodermal Tumors, Primitive, Peripheral
- Osteosarcoma
- Sarcoma
- Sarcoma, Ewing
- Solitary Fibrous Tumors
Recent trials (20)
- NCT05809830Lead sponsorPhase 1/Phase 2May 29, 2023
- NCT05146440Lead sponsorPhase 1/Phase 2Nov 30, 2021
- NCT05131386Lead sponsorPhase 2May 28, 2021
- NCT04595994Lead sponsorPhase 1Sep 2, 2020
- NCT04138381Lead sponsorPhase 1/Phase 2Aug 16, 2019
- NCT03985722Lead sponsorPhase 1Sep 21, 2018
- NCT03277924Lead sponsorPhase 1/Phase 2May 31, 2017
- NCT03275818Lead sponsorPhase 2May 9, 2017
- NCT03242382Lead sponsorPhase 2Mar 31, 2017
- NCT02638766Lead sponsorPhase 2Nov 1, 2015
- NCT02275286Lead sponsorPhase 1/Phase 2Nov 1, 2014
- NCT02066285Lead sponsorPhase 2Jun 1, 2014
- NCT01692496Lead sponsorPhase 2Jan 1, 2013
- NCT01710176CollaboratorPhase 3Jun 1, 2011
- NCT01684449Lead sponsorPhase 1/Phase 2Jan 1, 2010
Details
- Founded
- Madrid, ES Jan 1, 1994
- Last known activity
- May 29, 2023